1 completed, 1 recruiting. 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Muscular Dystrophy, Duchenne Type: new trials by email Literature Review of Muscular Dystrophy, Duchenne Type trials Research Report on Muscular Dystrophy, Duchenne Type
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO) Zeleciment Rostudirsen (DYNE-251), Placebo - Duchenne Muscular Dystrophy (DMD), Muscular Dystrophy, Duchenne | Phase 3 | Recruiting | Dyne Therapeutics | 90 | 2026-06-01 | 2026-05-27 |
| Trunk Oriented Exercises Versus Whole-body Vibration for Duchenne Muscular Dystrophy trunk oriented exercise, whole body vibration - Muscular Dystrophy, Duchenne Type | Not applicable | Completed | Cairo University | 30 | 2023-01-15 | 2023-04-18 |
Muscular Dystrophy, Duchenne (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Muscular Dystrophies (1) · Myotonic Dystrophy (1) · Neuromuscular Diseases (1)
Muscular Diseases (2) · Muscular Disorders, Atrophic (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Heredodegenerative Disorders, Nervous System (1) · Muscular Dystrophies (1) · Myotonic Disorders (1) · Neurodegenerative Diseases (1) · Neuromuscular Diseases (1)
Cairo University (1) · Dyne Therapeutics (1)
Egypt (1) · United States (1)
2025 (1)